Xenoscience, Inc.



Xenoscience, Inc. is an Arizona corporation founded in 1993 that has one single goal: To extend human life while saving the essence of who we are. Alzheimer's Disease, Multiple Sclerosis, Stroke, Neuropathy, changes the way people live. Migraines, Fibromyalgia, Parkinson's Disease, and other neurological diseases all take a toll on the light the shines within us. To that end we are engaged in the use of cutting edge technologies from companies that approach us with new ideas on how to enhance quality of life. Among other areas we are especially interested in new technologies which directly involved DNA/RNA. Problems with the basic code of life likely cause much of human suffering.

The combination of quality medical care, clinical research for various medical conditions, working with organizations developing nanotechnology, wetware including medical device implants, and pharmaceuticals will help us reach our goal.


Xenoscience personnel are members of or have been asked to speak at such organizations as the BioMems Conference on Nanotechnology, the Foresight Institute, the American Association for the Advancement of Science, the American Academy of Neurology, the American Neurological Association and the NanoSpace 2001 Symposium held in Galveston, Texas and sponsored by NASA.

In the past we have been proud to sponsor the annual Phoenix Memory Symposium. This was the largest clinical and caregiver conference on memory and memory disorders in the American Southwest.

Xenoscience, Inc. has the following divisions that operate under the above mandate:

Our clinical neurology practice operates under the name 21st Century Neurology. Located at 2601 N. 3rd Street, Suite 125, at the northeast corner of Virginia and 3rd Street. This is less than 1 mile from St. Joseph's Hospital and Barrow Neurological Institute in Phoenix, Arizona. Patient care is given the highest priority and practiced with the needs of the patient foremost in mind. Please call for an appointment: 602-265-6500, 9am-4pm Monday-Friday.

Our reseach division is also located in this facility - please use the link to find out what our current phase II - IV clinical trials are being offered.


Contact Information:
Xenoscience Corporate and Research Division: 602-274-9500
email: research@xenoscience.com




Visitors since 01/01/96